Based on available sources of information about the company’s shareholders as of 31 December 2018, it is estimated that shares were geographically distributed as shown in the chart below. As of 31 December 2018, the free float of listed B shares was 89.3%, excluding the Novo Holdings A/S holding and Novo Nordisk’s holding of treasury shares which, as of 31 December 2018, was DKK 41,109,130 nominally.
According to the Transparency Directive implemented in Denmark as of 1 June 2007
shareholders are obliged to notify both Novo Nordisk and the Danish Financial Supervisory Authority when the proportion of the voting rights conferred on the shares or the nominal value of the shares held by the shareholder as a result of the acquisition or disposal reaches, exceeds or falls below the thresholds of 5%, 10%, 15%, 20%, 25%, 1/3, 50%, 2/3,?90% or 100%. The voting rights shall be calculated on the basis of all the shares to which voting rights are attached even if the exercise thereof is suspended.
The notification shall as a minimum include the following information:
The notification shall be effected as soon as possible.
The notification to Novo Nordisk shall be made by post and email to the Head of Investor Relations. The notification to the Danish Financial Supervisory Authority shall be made electronically and using digital signature via the Danish Financial Supervisory Authority webpage.